Neuland Laboratories Limited (NEULANDLAB.NS) NSE

13,966.00

-865(-5.83%)

Updated at September 26 03:30PM

Currency In INR

Valuation

Market Cap147.34B
Enterprise Value147.59B
P/E Ratio101.79
PEG Ratio-3.15
Price/Sales Ratio13.48
Price/Book Ratio11.76
Enterprise/Revenue13.49
Enterprise/EBITDA57.21

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.13
Operating Margin0.12

Management Effectiveness

Return On Assets0.08
Return On Equity0.13

Income Statement

Revenue14.77B
Revenue/Share1,036.24
Gross Profit7.26B
EBITDA4.2B
Net Income2.6B
Diluted EPS202.74

Balance Sheet

Total Cash3.67B
Total Cash/Share285.4
Total Debt1.57B
Total Debt/Equity0.1
Current Ratio2.45
Book Value Per Share1,188.03

Price History

52-Week Change12.78
52-Week High18,100
52-Week Low10,190.7
Moving Average 50 Days14,031.62
Moving Average 200 Days12,932.4

Statistics

Average Volume91,981
Shares Outstanding12.83M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate12
Trailing Annual Dividend Yield0.09
Payout Ratio0
Last Split Factor523:500
Last Split DateAugust 13, 2014